感染性呼吸器疾患診断の市場規模、シェア&動向分析:製品タイプ別(機器、サービス)、サンプルタイプ別(血液、NPS)、アプリケーション別、技術別、セグメント予測、2022年~2030年Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis By Product Type (Instruments, Services), By Sample Type (Blood, NPS), By Application, By Technology, And Segment Forecasts, 2022 - 2030 感染性呼吸器疾患診断薬市場の成長とトレンド グランドビューリサーチ社の最新レポートによると、感染性呼吸器疾患診断の世界市場規模は、2030年までに436億米ドルに達し、予測期間中に-1.8%のCAGRを記録する... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー感染性呼吸器疾患診断薬市場の成長とトレンドグランドビューリサーチ社の最新レポートによると、感染性呼吸器疾患診断の世界市場規模は、2030年までに436億米ドルに達し、予測期間中に-1.8%のCAGRを記録すると予測されています。市場規模の減少は、主にCOVID-19検査の減少に起因しています。しかし、COVID-19の影響を受けない市場は、予測期間中に成長すると予想されます。この成長は、感染性呼吸器疾患の有病率の増加、および需要の増加に対応するために政府および非営利団体が新規および革新的な製品を導入するために行っているイニシアチブに起因していると考えられます。例えば、結核研究開発への世界的な投資は9億1500万米ドルに達し、2020年には米国政府によって約4億100万米ドルが結核の研究に費やされました。 予測期間中、世界の産業は、結核、RSV、インフルエンザなどの感染性呼吸器疾患の発生率の上昇によって牽引されると予想されます。国連によると、肺炎は毎年約420万人が罹患しています。主要企業は、感染症診断のための診断薬や消耗品の需要増に対応するため、生産性を向上させる革新的な技術の開発に取り組んでいます。例えば、オプトインダストリー社は、COVID-19の大流行によるサンプル採取キットの供給不足に対処するため、3Dプリントシステムを活用したInstaSwabを発表しました。この綿棒は、格子を編んで作られており、従来の綿棒よりも多くの液体を吸収・放出することができます。企業は、ターゲットに特化した正確な結果を得るために新しい技術を使用することで、診断製品を進化させています。 キヤノン株式会社は、2021年3月にデジタルX線用の内蔵型AECアシストを開発したと発表した。X線イメージセンサーにより、放出されたX線に対応する画像生成とリアルタイム検出を行うことができる。さらに、2021年5月には、チップ技術を利用してSARS-CoV-2やインフルエンザA抗原の有無を識別する超高感度分子検査法を開発した。また、RSV、インフルエンザ、COVID-19の呼吸器疾患を同時に診断するためのマルチプレックス検査も各社から発売されています。RT-PCR検査は、患者のCOVID-19の診断のためのゴールドスタンダードと考えられています。しかし、分子検査に関連する高価格は、この市場を阻害する主な要因の1つです。 類似製品の不足も価格高騰の原因となっています。この問題は、各分子診断製品の用途によって価格が大きく異なることで、さらに深刻化しています。企業は、感染性呼吸器疾患診断製品の浸透を高めるために、新製品の上市や提携などの戦略を採用しています。例えば、2021年8月、サーモフィッシャーサイエンティフィック社は、TaqPath COVID-19 RNase P Combo KitとTaqPath COVID-19 Fast PCR Combo Kitという2つのCOVID-19診断製品の米国市場への導入についてEUAを受けています。 感染性呼吸器疾患診断薬市場レポートハイライト - 2021年には、COVID-19診断のための高い検査率と近年の複数のアッセイの製品化により、消耗品セグメントが最大の収益シェアを占め、予測期間中もその優位性を維持すると予想される - COVID-19診断におけるPCR技術の利用が増加していることから、2021年には分子診断薬が最も高い売上シェアを占めた - COVID-19診断における高い使用率により、鼻咽頭スワブサンプルタイプのセグメントが2021年に最も高い売上高シェアを占めた - COVID-19用途分野は、高い発症率、製品承認の増加、革新的な製品を発売するための高い研究開発イニシアチブなどの要因により、2021年の業界をリードしている - 結核は、診断薬の開発に対する政府の注力と研究開発資金の増加により、予測期間において最も速いCAGRを示すと予想される - IVD製品の普及率の上昇、可処分所得の増加、低開発国における結核の高い有病率により、予測期間中、アジア太平洋地域が最も速い成長を遂げると予測される 目次Table of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation and Scope 1.1.1 Segment Scope 1.1.2 Regional Scope 1.1.3 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 Gvr’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details Of Primary Research 1.4 Information Or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis 1.6.1.1 Approach: Commodity Flow Approach 1.7 Research Assumptions 1.8 List of Secondary Sources 1.9 List of Abbreviations 1.10 Objectives 1.10.1 Objective 1 1.10.2 Objective 2 1.10.3 Objective 3 1.10.4 Objective 4 Chapter 2 Executive Summary 2.1 Market Outlook Chapter 3 Infectious Respiratory Disease Diagnostics Market Variables, Trends, and Scope 3.1 Penetration and Growth Prospect Mapping 3.2 Market Driver analysis 3.2.1 High Prevalence Of Infectious Respiratory Diseases Globally 3.2.2 Technological Advancement In Respiratory Disease Testing 3.2.3 Rising R&D Investments In Respiratory Disease Testing 3.3 Market Restraint Analysis 3.3.1 High Prices Of Diagnostic Products 3.3.2 Presence Of Ambiguous Regulatory Framework 3.4 Market Opportunity Analysis 3.4.1 Increasing Adoption Of Self-Testing Products And Point-Of-Care Products 3.4.2 Increasing Focus On Introducing Multiplex Pcr 3.5 Covid Impact Analysis 3.6 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological) 3.7 Industry Analysis - Porter’s 3.8 Multiplex testing in infectious respiratory disease testing, market opportunity Chapter 4 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Product Type, 2018 - 2030 (USD Million) 4.1 Definitions and Scope 4.2 Infectious Respiratory Disease Diagnostics Market: Product Type Movement Analysis 4.3 Instruments 4.3.1 Instruments Market, 2018 - 2030 (USD Million) 4.3.2 Imaging Tests 4.3.2.1 Imaging Tests Market, 2018 - 2030 (USD Million) 4.3.3 Respiratory Measurement Devices 4.3.3.1 Respiratory Measurement Devices Market, 2018 - 2030 (USD Million) 4.3.4 Other Instruments 4.3.4.1 Other Instruments Market, 2018 - 2030 (USD Million) 4.4 Consumables 4.4.1 Consumables Market, 2018 - 2030 (USD Million) 4.5 Services 4.5.1 Services Market, 2018 - 2030 (USD Million) Chapter 5 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Sample Type, 2018 - 2030 (USD Million) 5.1 Definitions & Scope 5.2 Infectious Respiratory Disease Diagnostics Market: Sample Type Movement Analysis 5.3 Saliva 5.3.1 Saliva Market, 2018 - 2030 (USD Million) 5.4 Nasopharyngeal Swabs (Nps) 5.4.1 Nasopharyngeal Swabs (Nps) Market, 2018 - 2030 (USD Million) 5.5 Anterior Nasal Region 5.5.1 Anterior Nasal Region Market, 2018 - 2030 (USD Million) 5.6 Blood 5.6.1 Blood Market, 2018 - 2030 (USD Million) 5.7 Others 5.7.1 Others Market, 2018 - 2030 (USD Million) Chapter 6 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Technology, 2018 - 2030 (USD Million) 6.1 Definitions and Scope 6.2 Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis 6.3 Immunoassay 6.3.1 Immunoassay Market, 2018 - 2030 (USD Million) 6.4 Molecular Diagnostics 6.4.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million) 6.5 Microbiology 6.5.1 Microbiology Market, 2018 - 2030 (USD Million) 6.6 Other Technologies 6.6.1 Other Technologies Market, 2018 - 2030 (USD Million) Chapter 7 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Application, 2018 - 2030 (USD Million) (‘000) 7.1 Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis 7.2 COVID-19 7.2.1 Covid-19 Market, 2018 - 2030 (USD Million) 7.2.2 Covid-19 Market, 2018 - 2030 (Volume ‘000) 7.3 Influenza 7.3.1 Influenza Market, 2018 - 2030 (USD Million) 7.3.2 Influenza Market, 2018 - 2030 (Volume ‘000) 7.4 Respiratory Syncytial Virus 7.4.1 Respiratory Syncytial Virus Market, 2018 - 2030 (USD Million) 7.4.2 Respiratory Syncytial Virus Market, 2018 - 2030 (Volume ‘000) 7.5 Tuberculosis 7.5.1 Tuberculosis Market, 2018 - 2030 (USD Million) 7.5.2 Tuberculosis Market, 2018 - 2030 (Volume ‘000) 7.6 Streptococcus Testing 7.6.1 Streptococcus Testing Market, 2018 - 2030 (USD Million) 7.6.2 Streptococcus Testing Market, 2018 - 2030 (Volume ‘000) 7.7 Other Respiratory Disease Testing 7.7.1 Other Respiratory Disease Testing Market, 2018 - 2030 (USD Million) 7.7.2 Other Respiratory Disease Testing Market, 2018 - 2030 (Volume ‘000) Chapter 8 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by End-use, 2018 - 2030 (USD Million) 8.1 Infectious Respiratory Disease Diagnostics Market: End-use Movement Analysis 8.2 Hospitals 8.2.1 Hospitals Market, 2018 - 2030 (USD Million) 8.3 Diagnostic Laboratories 8.3.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Million) 8.4 Physician Offices 8.4.1 Physician Offices Market, 2018 - 2030 (USD Million) 8.5 Other End-Users 8.5.1 Other End-Users Market, 2018 - 2030 (USD Million) Chapter 9 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Region, 2018 - 2030 (USD Million) 9.1 Market Share Analysis 9.2 Regional Market Share Analysis, 2021 & 2030 9.3 Regional Market Snapshot 9.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030 9.4.1 North America 9.4.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million) 9.4.1.2 U.S. 9.4.1.2.1 U.S. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.1.3 Canada 9.4.1.3.1 Canada Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2 Europe 9.4.2.1 Europe Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.2 U.K. 9.4.2.2.1 U.K. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.3 Germany 9.4.2.3.1 Germany Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.4 Spain 9.4.2.4.1 Spain Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.5 France 9.4.2.5.1 France Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.6 Italy 9.4.2.6.1 Italy Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.7 Russia 9.4.2.7.1 Russia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3 Asia Pacific 9.4.3.1 Asia Pacific Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.2 Japan 9.4.3.2.1 Japan Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.3 China 9.4.3.3.1 China Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.4 India 9.4.3.4.1 India Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.5 South Korea 9.4.3.5.1 South Korea Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.6 Australia 9.4.3.6.1 Australia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.7 Singapore 9.4.3.7.1 Singapore Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.4 Latin America 9.4.4.1 Latin America Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.4.2 Brazil 9.4.4.2.1 Brazil Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.4.3 Mexico 9.4.4.3.1 Mexico Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.4.4 Argentina 9.4.4.4.1 Argentina Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.5 MEA 9.4.5.1 MEA Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.5.2 South Africa 9.4.5.2.1 South Africa Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.5.3 Saudi Arabia 9.4.5.3.1 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.5.4 UAE 9.4.5.4.1 UAE Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) Chapter 10 Infectious Respiratory Disease Diagnostics Market: Competitive Analysis 10.1 Recent Developments and Impact Analysis, by Key Market Participants 10.1.1 New Product Launches 10.1.2 Mergers And Acquisitions 10.1.3 Partnerships And Strategic Collaboration 10.1.4 Conferences And Campaigns 10.2 Company Categorization 10.2.1 Innovators 10.2.2 Market Leaders 10.2.3 Heat Map Analysis 10.3 Vendor Landscape 10.3.1 List Of Key Distributors And Channel Partners 10.3.2 Key Customers 10.4 Key Company Market Share Analysis, 2021 10.5 Public Companies 10.5.1 Company Market Position Analysis 10.5.2 Company Market Position Analysis 10.5.3 Competitive Dashboard Analysis 10.5.3.1 Market Differentiators 10.6 Private Companies 10.6.1 List Of Key Emerging Companies 10.6.2 Regional Network Map 10.7 Company Profiles 10.7.1 ABBOTT 10.7.1.1 Company overview 10.7.1.2 Financial performance 10.7.1.3 Product benchmarking 10.7.1.4 Strategic initiatives 10.7.2 THERMO FISHER SCIENTIFIC, INC. 10.7.2.1 Company overview 10.7.2.2 Financial performance 10.7.2.3 Product benchmarking 10.7.2.4 Strategic initiatives 10.7.3 KONINKLIJKE PHILIPS N.V. 10.7.3.1 Company overview 10.7.3.2 Financial performance 10.7.3.3 Product benchmarking 10.7.3.4 Strategic initiatives 10.7.4 F. HOFFMANN-LA ROCHE LTD 10.7.4.1 Company overview 10.7.4.2 Financial performance 10.7.4.3 Product benchmarking 10.7.4.4 Strategic initiatives 10.7.5 BIOMÉRIEUX SA 10.7.5.1 Company overview 10.7.5.2 Financial performance 10.7.5.3 Product benchmarking 10.7.5.4 Strategic initiatives 10.7.6 BIO-RAD LABORATORIES, INC. 10.7.6.1 Company overview 10.7.6.2 Financial performance 10.7.6.3 Product benchmarking 10.7.6.4 Strategic initiatives 10.7.7 QUIDEL CORPORATION 10.7.7.1 Company overview 10.7.7.2 Financial performance 10.7.7.3 Product benchmarking 10.7.7.4 Strategic initiatives 10.7.8 CEPHEID (DANAHER) 10.7.8.1 Company Overview 10.7.8.2 Financial Performance 10.7.8.3 Product Benchmarking 10.7.8.4 Strategic Initiatives 10.7.9 QIAGEN 10.7.9.1 Company Overview 10.7.9.2 Financial Performance 10.7.9.3 Product Benchmarking 10.7.9.4 Strategic Initiatives 10.7.10 SIEMENS HEALTHCARE GMBH 10.7.10.1 Company Overview 10.7.10.2 Financial Performance 10.7.10.3 Product Benchmarking 10.7.10.4 Strategic Initiatives
SummaryInfectious Respiratory Disease Diagnostics Market Growth & Trends Table of ContentsTable of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation and Scope 1.1.1 Segment Scope 1.1.2 Regional Scope 1.1.3 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 Gvr’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details Of Primary Research 1.4 Information Or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis 1.6.1.1 Approach: Commodity Flow Approach 1.7 Research Assumptions 1.8 List of Secondary Sources 1.9 List of Abbreviations 1.10 Objectives 1.10.1 Objective 1 1.10.2 Objective 2 1.10.3 Objective 3 1.10.4 Objective 4 Chapter 2 Executive Summary 2.1 Market Outlook Chapter 3 Infectious Respiratory Disease Diagnostics Market Variables, Trends, and Scope 3.1 Penetration and Growth Prospect Mapping 3.2 Market Driver analysis 3.2.1 High Prevalence Of Infectious Respiratory Diseases Globally 3.2.2 Technological Advancement In Respiratory Disease Testing 3.2.3 Rising R&D Investments In Respiratory Disease Testing 3.3 Market Restraint Analysis 3.3.1 High Prices Of Diagnostic Products 3.3.2 Presence Of Ambiguous Regulatory Framework 3.4 Market Opportunity Analysis 3.4.1 Increasing Adoption Of Self-Testing Products And Point-Of-Care Products 3.4.2 Increasing Focus On Introducing Multiplex Pcr 3.5 Covid Impact Analysis 3.6 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological) 3.7 Industry Analysis - Porter’s 3.8 Multiplex testing in infectious respiratory disease testing, market opportunity Chapter 4 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Product Type, 2018 - 2030 (USD Million) 4.1 Definitions and Scope 4.2 Infectious Respiratory Disease Diagnostics Market: Product Type Movement Analysis 4.3 Instruments 4.3.1 Instruments Market, 2018 - 2030 (USD Million) 4.3.2 Imaging Tests 4.3.2.1 Imaging Tests Market, 2018 - 2030 (USD Million) 4.3.3 Respiratory Measurement Devices 4.3.3.1 Respiratory Measurement Devices Market, 2018 - 2030 (USD Million) 4.3.4 Other Instruments 4.3.4.1 Other Instruments Market, 2018 - 2030 (USD Million) 4.4 Consumables 4.4.1 Consumables Market, 2018 - 2030 (USD Million) 4.5 Services 4.5.1 Services Market, 2018 - 2030 (USD Million) Chapter 5 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Sample Type, 2018 - 2030 (USD Million) 5.1 Definitions & Scope 5.2 Infectious Respiratory Disease Diagnostics Market: Sample Type Movement Analysis 5.3 Saliva 5.3.1 Saliva Market, 2018 - 2030 (USD Million) 5.4 Nasopharyngeal Swabs (Nps) 5.4.1 Nasopharyngeal Swabs (Nps) Market, 2018 - 2030 (USD Million) 5.5 Anterior Nasal Region 5.5.1 Anterior Nasal Region Market, 2018 - 2030 (USD Million) 5.6 Blood 5.6.1 Blood Market, 2018 - 2030 (USD Million) 5.7 Others 5.7.1 Others Market, 2018 - 2030 (USD Million) Chapter 6 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Technology, 2018 - 2030 (USD Million) 6.1 Definitions and Scope 6.2 Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis 6.3 Immunoassay 6.3.1 Immunoassay Market, 2018 - 2030 (USD Million) 6.4 Molecular Diagnostics 6.4.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million) 6.5 Microbiology 6.5.1 Microbiology Market, 2018 - 2030 (USD Million) 6.6 Other Technologies 6.6.1 Other Technologies Market, 2018 - 2030 (USD Million) Chapter 7 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Application, 2018 - 2030 (USD Million) (‘000) 7.1 Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis 7.2 COVID-19 7.2.1 Covid-19 Market, 2018 - 2030 (USD Million) 7.2.2 Covid-19 Market, 2018 - 2030 (Volume ‘000) 7.3 Influenza 7.3.1 Influenza Market, 2018 - 2030 (USD Million) 7.3.2 Influenza Market, 2018 - 2030 (Volume ‘000) 7.4 Respiratory Syncytial Virus 7.4.1 Respiratory Syncytial Virus Market, 2018 - 2030 (USD Million) 7.4.2 Respiratory Syncytial Virus Market, 2018 - 2030 (Volume ‘000) 7.5 Tuberculosis 7.5.1 Tuberculosis Market, 2018 - 2030 (USD Million) 7.5.2 Tuberculosis Market, 2018 - 2030 (Volume ‘000) 7.6 Streptococcus Testing 7.6.1 Streptococcus Testing Market, 2018 - 2030 (USD Million) 7.6.2 Streptococcus Testing Market, 2018 - 2030 (Volume ‘000) 7.7 Other Respiratory Disease Testing 7.7.1 Other Respiratory Disease Testing Market, 2018 - 2030 (USD Million) 7.7.2 Other Respiratory Disease Testing Market, 2018 - 2030 (Volume ‘000) Chapter 8 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by End-use, 2018 - 2030 (USD Million) 8.1 Infectious Respiratory Disease Diagnostics Market: End-use Movement Analysis 8.2 Hospitals 8.2.1 Hospitals Market, 2018 - 2030 (USD Million) 8.3 Diagnostic Laboratories 8.3.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Million) 8.4 Physician Offices 8.4.1 Physician Offices Market, 2018 - 2030 (USD Million) 8.5 Other End-Users 8.5.1 Other End-Users Market, 2018 - 2030 (USD Million) Chapter 9 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Region, 2018 - 2030 (USD Million) 9.1 Market Share Analysis 9.2 Regional Market Share Analysis, 2021 & 2030 9.3 Regional Market Snapshot 9.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030 9.4.1 North America 9.4.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million) 9.4.1.2 U.S. 9.4.1.2.1 U.S. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.1.3 Canada 9.4.1.3.1 Canada Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2 Europe 9.4.2.1 Europe Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.2 U.K. 9.4.2.2.1 U.K. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.3 Germany 9.4.2.3.1 Germany Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.4 Spain 9.4.2.4.1 Spain Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.5 France 9.4.2.5.1 France Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.6 Italy 9.4.2.6.1 Italy Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.2.7 Russia 9.4.2.7.1 Russia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3 Asia Pacific 9.4.3.1 Asia Pacific Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.2 Japan 9.4.3.2.1 Japan Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.3 China 9.4.3.3.1 China Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.4 India 9.4.3.4.1 India Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.5 South Korea 9.4.3.5.1 South Korea Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.6 Australia 9.4.3.6.1 Australia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.3.7 Singapore 9.4.3.7.1 Singapore Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.4 Latin America 9.4.4.1 Latin America Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.4.2 Brazil 9.4.4.2.1 Brazil Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.4.3 Mexico 9.4.4.3.1 Mexico Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.4.4 Argentina 9.4.4.4.1 Argentina Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.5 MEA 9.4.5.1 MEA Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.5.2 South Africa 9.4.5.2.1 South Africa Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.5.3 Saudi Arabia 9.4.5.3.1 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) 9.4.5.4 UAE 9.4.5.4.1 UAE Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million) Chapter 10 Infectious Respiratory Disease Diagnostics Market: Competitive Analysis 10.1 Recent Developments and Impact Analysis, by Key Market Participants 10.1.1 New Product Launches 10.1.2 Mergers And Acquisitions 10.1.3 Partnerships And Strategic Collaboration 10.1.4 Conferences And Campaigns 10.2 Company Categorization 10.2.1 Innovators 10.2.2 Market Leaders 10.2.3 Heat Map Analysis 10.3 Vendor Landscape 10.3.1 List Of Key Distributors And Channel Partners 10.3.2 Key Customers 10.4 Key Company Market Share Analysis, 2021 10.5 Public Companies 10.5.1 Company Market Position Analysis 10.5.2 Company Market Position Analysis 10.5.3 Competitive Dashboard Analysis 10.5.3.1 Market Differentiators 10.6 Private Companies 10.6.1 List Of Key Emerging Companies 10.6.2 Regional Network Map 10.7 Company Profiles 10.7.1 ABBOTT 10.7.1.1 Company overview 10.7.1.2 Financial performance 10.7.1.3 Product benchmarking 10.7.1.4 Strategic initiatives 10.7.2 THERMO FISHER SCIENTIFIC, INC. 10.7.2.1 Company overview 10.7.2.2 Financial performance 10.7.2.3 Product benchmarking 10.7.2.4 Strategic initiatives 10.7.3 KONINKLIJKE PHILIPS N.V. 10.7.3.1 Company overview 10.7.3.2 Financial performance 10.7.3.3 Product benchmarking 10.7.3.4 Strategic initiatives 10.7.4 F. HOFFMANN-LA ROCHE LTD 10.7.4.1 Company overview 10.7.4.2 Financial performance 10.7.4.3 Product benchmarking 10.7.4.4 Strategic initiatives 10.7.5 BIOMÉRIEUX SA 10.7.5.1 Company overview 10.7.5.2 Financial performance 10.7.5.3 Product benchmarking 10.7.5.4 Strategic initiatives 10.7.6 BIO-RAD LABORATORIES, INC. 10.7.6.1 Company overview 10.7.6.2 Financial performance 10.7.6.3 Product benchmarking 10.7.6.4 Strategic initiatives 10.7.7 QUIDEL CORPORATION 10.7.7.1 Company overview 10.7.7.2 Financial performance 10.7.7.3 Product benchmarking 10.7.7.4 Strategic initiatives 10.7.8 CEPHEID (DANAHER) 10.7.8.1 Company Overview 10.7.8.2 Financial Performance 10.7.8.3 Product Benchmarking 10.7.8.4 Strategic Initiatives 10.7.9 QIAGEN 10.7.9.1 Company Overview 10.7.9.2 Financial Performance 10.7.9.3 Product Benchmarking 10.7.9.4 Strategic Initiatives 10.7.10 SIEMENS HEALTHCARE GMBH 10.7.10.1 Company Overview 10.7.10.2 Financial Performance 10.7.10.3 Product Benchmarking 10.7.10.4 Strategic Initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Grand View Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |